A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Name: A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Published: 2023
License: Public Domain

Guangzhou Lupeng Pharmaceutical Company LTD. · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, myelodysplastic syndromes, chronic myelomonocytic leukemia, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Related documents